MedTrace Logo

Population Pharmacokinetics of Anti-infectious Drugs in Children

NCT01344512 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 214

Last updated 2015-03-18

No results posted yet for this study

Summary

The Pharm A project is a French national collaborative project aiming to determine the population pharmacokinetics of ceftazidime, ciprofloxacin, and voriconazole in paediatric patients aged one month to five years.

Conditions

Interventions

DRUG

Ceftazidime

Bloods sampling on patient treated with Ceftazidime between 48 hours and 4 days after beginning of treatment.

DRUG

Ciprofloxacin

Bloods sampling on patient treated with Ciprofloxacin between 48 hours and 4 days after beginning of treatment.

DRUG

Voriconazole

Bloods sampling on patient treated with Voriconazole between 48 hours and 4 days after beginning of treatment.

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Stéphanie Bui, Dr · University Hospital Bordeaux, France

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
28 Days
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01344512 on ClinicalTrials.gov